Global Sexually Transmitted Diseases Testing Devices Market By Type (Thermal Cyclers, Lateral Flow Readers, Flow Cytometers, Differential Light Scattering Machines, and Others), By Application (Laboratory Testing, and Point of Care Testing), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 139431
- 18-Dec
- PDF/PPT/Word
-
Report Details
Global Sexually Transmitted Diseases Testing Devices Market is estimated to be valued US$ XX.X million in 2019. The report on Sexually Transmitted Diseases Testing Devices Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global sexually transmitted diseases testing devices market is segmented on the basis of Type, Application, and geography.
Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.
Sexually Transmitted Diseases Testing Devices Market Scope:
By type, the market is segmented into Thermal Cyclers, Lateral Flow Readers, Flow Cytometers, Differential Light Scattering Machines, and Others. By Application, the market is divided into Laboratory Testing, and Point of Care Testing.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Roche Diagnostics, BioMerieux, Hologic, Becton Dickinson & Company, Cepheid, Danaher Corporation, Affymetrix, Alere, Abbott Laboratories, and DiaSorin.Key Market Segments
Type
Thermal Cyclers
Lateral Flow Readers
Flow Cytometers
Differential Light Scattering Machines
Others
Application
Laboratory Testing
Point of Care Testing
Key Market Players included in the report:
Roche Diagnostics
BioMerieux
Hologic
Becton Dickinson & Company
Cepheid
Danaher Corporation
Affymetrix
Alere
Abbott Laboratories
DiaSorin
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Sexually Transmitted Diseases Testing Devices Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Sexually Transmitted Diseases Testing Devices Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Sexually Transmitted Diseases Testing Devices Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Sexually Transmitted Diseases Testing Devices Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Sexually Transmitted Diseases Testing Devices Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Sexually Transmitted Diseases Testing Devices Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Sexually Transmitted Diseases Testing Devices sub-markets, depending on key regions (various vital states).
To analyze Sexually Transmitted Diseases Testing Devices Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Sexually Transmitted Diseases Testing Devices Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide Sexually Transmitted Diseases Testing Devices Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Sexually Transmitted Diseases Testing Devices Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Sexually Transmitted Diseases Testing Devices Market Overview
3.1. Sexually Transmitted Diseases Testing Devices Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Sexually Transmitted Diseases Testing Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global Sexually Transmitted Diseases Testing Devices Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Thermal Cyclers4.4. Lateral Flow Readers
4.5. Flow Cytometers
4.6. Differential Light Scattering Machines
4.7. Others
5. Global Sexually Transmitted Diseases Testing Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Sexually Transmitted Diseases Testing Devices Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Laboratory Testing5.4. Point of Care Testing
6. Global Sexually Transmitted Diseases Testing Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Sexually Transmitted Diseases Testing Devices Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Sexually Transmitted Diseases Testing Devices Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Sexually Transmitted Diseases Testing Devices Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Sexually Transmitted Diseases Testing Devices Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Sexually Transmitted Diseases Testing Devices Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA7. Global Sexually Transmitted Diseases Testing Devices Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. Roche Diagnostics7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. BioMerieux
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Hologic
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Becton Dickinson & Company
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Cepheid
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Danaher Corporation
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Affymetrix
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Alere
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Abbott Laboratories
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. DiaSorin
7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
